Results 1 to 10 of about 20 (20)
Some of the next articles are maybe not open access.

Platinum-based drugs and hydrogel: a promising anti-tumor combination

Drug Delivery, 2023
Hang Zhao, Yao Yuan
exaly  

Novel Strategies for Cancer Combat: Drug Combination Using Repurposed Drugs Induces Synergistic Growth Inhibition of MCF-7 Breast and HT-29 Colon Cancer Cells

Current Issues in Molecular Biology, 2022
Diana Duarte, Nuno Vale, Duarte Diana
exaly  

Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action

Biomolecules, 2022
Diana Duarte   +2 more
exaly  

Idarubicin/mithramycin-acridine orange combination drugs co-loaded by DNA nanostructures: Different effects of intercalation and groove binding on drug release and cytotoxicity

Journal of Molecular Liquids, 2022
Yushu Wu, Tianxin Weng, Yanna Zhao
exaly  

Combination of Antiretroviral Drugs Zidovudine and Efavirenz Impairs Tumor Growths in a Mouse Model of Cancer

Viruses, 2021
Marcel André Schneider   +2 more
exaly  

Drugs that lack single-agent activity: are they worth pursuing in combination?

Nature Reviews Clinical Oncology, 2017
Bishal Gyawali   +2 more
exaly  

Are two drugs better than one? A review of combination therapies for hypertension

Expert Opinion on Pharmacotherapy, 2017
Yogita Rochlani
exaly  

Combination of metformin with chemotherapeutic drugs via different molecular mechanisms

Cancer Treatment Reviews, 2017
Ting Tao, Qiongli Su, Shi Yin
exaly  

Thermodynamics, in vitro release and cytotoxity studies on doxorubicin–toluidine blue O combination drugs co-loaded in aptamer-tethered DNA nanostructures

Journal of Molecular Liquids, 2020
Yushu Wu, Yanna Zhao, Bin Sun
exaly  

Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs

Journal of Controlled Release, 2014
Ela Markovsky   +2 more
exaly  
1  2  

Home - About - Disclaimer - Privacy